Leesa Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 16.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 21.50 Cr
- Revenue Growth %
- Net Worth -6.79%
- Total Assets -16.33%
About Leesa Lifesciences
Leesa Lifesciences Private Limited (LLPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2007 and has a history of 17 years and two months. Its registered office is in Mahabub Nagar, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company has closed loans amounting to ₹21.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kasthur Nemallapudi and Ramadevi Nemallapudi serve as directors at the Company.
Company Details
-
Location
Mahabub Nagar, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2007PTC056228
-
Company No.
056228
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Nov 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Leesa Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kasthur Nemallapudi
|
Director | 18-Oct-2022 | Current |
|
Ramadevi Nemallapudi
|
Director | 18-Oct-2022 | Current |
Financial Performance of Leesa Lifesciences.
Leesa Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 6.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leesa Lifesciences?
In 2023, Leesa Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Psn Medicare Private LimitedKasthur Nemallapudi and Ramadevi Nemallapudi are mutual person
Charges (Loans)
₹0
₹21.50 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 21.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2009 | State Bank Of India | ₹21.50 Cr | Satisfied |
How Many Employees Work at Leesa Lifesciences?
Unlock and access historical data on people associated with Leesa Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leesa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leesa Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
